維爾利(300190.SZ)簽訂長春市城市生活垃圾處理中心滲濾液處理項目合同
格隆匯6月8日丨維爾利(300190.SZ)公佈,近日,公司與長春市固體廢棄物管理中心簽訂了《長春市城市生活垃圾處理中心滲濾液處理項目合同》。根據該項目的運營期限、處理水量、運營單價等相關要素估算,該項目的合同總金額預計約為約6.3億元。
該合同的簽訂進一步鞏固了公司在國內大中型滲濾液處理項目的市場地位,其有利於進一步提高公司滲濾液處理項目運營服務能力,擴大公司委託運營收入的規模,增強公司未來業績水平的持續性,進而提升公司市場競爭力。由於本項目期限較長、項目內容較多,可能受到氣候、外界人力或不可抗力等因素的影響,使得該項目在執行過程中具有一定的風險因素。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.